The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
Honorable Vice-President of India C. P. Radhakrishnan has released the book called 'Tides of Time:…
To strengthen the India's maritime security Indian Navy has commissioned the latest stealth frigate called…
Mobile Phones are a very important part of our daily life. From calling and messaging…
Mongolian parliament has appointed the Uchral Nyam-Osor as the country' new Prime Minister. With this…
To boost export potential of Indian textile industries Ministry of Textiles has extended the RoSCTL…
From the April 1st fuel stations across the country are now supplying that petrol which…